Latest news with #LENSAR
Yahoo
01-07-2025
- Business
- Yahoo
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ('LENSAR' or the 'Company') today announced that a majority of the independent members of LENSAR's board of directors granted three newly-hired non-executive employees an aggregate of 660 restricted stock units ('RSUs'). The RSUs were granted as of July 1, 2025, as inducement for each such employee commencing employment with the Company. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in four substantially equal installments on each anniversary of the grant date, subject to the new employee's continued service with the Company through the applicable vesting date. The RSUs are subject to the terms and conditions of LENSAR's 2024 Employment Inducement Incentive Award Plan and a restricted stock unit agreement covering the grant. About LENSAR LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY Robotic Cataract Laser System™ as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR's advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR's proprietary Streamline® software technology, designed to guide surgeons to achieve better outcomes. Contacts: Lee Roth / Cameron Radinovic Thomas R. Staab, II, CFO Burns McClellan for LENSAR lroth@ / cradinovic@
Associated Press
19-05-2025
- Business
- Associated Press
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Landsea Homes Corporation (Nasdaq - LSEA), LENSAR, Inc. (Nasdaq - LNSR), AvidXchange Holdings, Inc. (Nasdaq – AVDX), FARO Technologies, Inc. (Nasdaq – FARO)
BALA CYNWYD, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847. There is no cost or financial obligation to you. Landsea Homes Corporation (Nasdaq - LSEA) Under the terms of the agreement, Landsea Homes will be acquired by New Home Co. ('New Home') for $11.30 per share in cash. The investigation concerns whether the Landsea Homes Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders. For example, the deal consideration is below the 52-week high of $14.04 for the Company's shares. Additional information can be found at LENSAR, Inc. (Nasdaq - LNSR) Under the terms of the Merger Agreement, LENSAR will be acquired by Alcon for $14.00 per share in cash for each LENSAR share, with an additional non-tradeable contingent value right offering up to $2.75 per share in cash, conditioned on achievement of 614,000 cumulative procedures with LENSAR's products between January 1, 2026, and December 31, 2027. The investigation concerns whether the LENSAR Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company's shareholders are receiving fair value for their shares. Additional information can be found at AvidXchange Holdings, Inc. (Nasdaq – AVDX) Under the terms of the agreement, AvidXchange Holdings will be acquired by TPG (Nasdaq – TPG) for $10.00 a share in cash in a transaction that values AvidXchange Holdings at $2.2 billion. The investigation concerns whether the AvidXchange Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders. Additional information can be found at FARO Technologies, Inc. (Nasdaq – FARO) Under the terms of the Merger Agreement, FARO will be acquired by AMETEK, Inc. (NYSE - AME) for $44 per share in cash. The investigation concerns whether the FARO Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of the Company's shareholders in the combined company. Additional information can be found at Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
Associated Press
15-05-2025
- Business
- Associated Press
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, DNB, BRDG on Behalf of Shareholders
NEW YORK, May 15, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: LENSAR, Inc. (NASDAQ: LNSR)'s sale to Alcon for $14.00 per share in cash, with an additional non-tradeable contingent value right offering up to $2.75 per share in cash conditioned on achievement of a milestone. If you are a LENSAR shareholder, click here to learn more about your legal rights and options. Dun & Bradstreet Holdings, Inc. (NYSE: DNB)'s sale to Clearlake Capital Group, L.P. for $9.15 in cash per share. If you are a Dun & Bradstreet shareholder, click here to learn more about your legal rights and options. Bridge Investment Group Holdings Inc. (NYSE: BRDG)'s sale to Apollo. Under the terms of the proposed transaction, Bridge shareholders and Bridge OpCo unitholders will receive, at closing, 0.07081 shares of Apollo stock for each share of Bridge Class A common stock and each Bridge OpCo Class A common unit, respectively. If you are a Bridge shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 [email protected] [email protected] View original content to download multimedia: SOURCE Halper Sadeh LLP
Yahoo
10-04-2025
- Business
- Yahoo
Is LENSAR (LNSR) a Deeply Undervalued Stock?
Cedar Grove Capital Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 0.38% in the first quarter compared to -4.27% for the S&P 500 and -9.51% for the Russell 2000. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first quarter 2025 investor letter, Cedar Grove Capital Management emphasized stocks such as LENSAR, Inc. (NASDAQ:LNSR). LENSAR, Inc. (NASDAQ:LNSR) is a commercial-stage medical device company. The one-month return of LENSAR, Inc. (NASDAQ:LNSR) was -6.64%, and its shares gained 325.94% of their value over the last 52 weeks. On April 9, 2025, LENSAR, Inc. (NASDAQ:LNSR) stock closed at $13.63 per share with a market capitalization of $160.703 million. Cedar Grove Capital Management stated the following regarding LENSAR, Inc. (NASDAQ:LNSR) in its Q1 2025 investor letter: "LENSAR, Inc. (NASDAQ:LNSR) was a recent name that we pitched long near the end of February, calling it deeply undervalued and having many characteristics that were ideal for an outsized return in the coming years. A hand using a laser to perform corneal astigmatism surgery. LENSAR, Inc. (NASDAQ:LNSR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 5 hedge fund portfolios held LENSAR, Inc. (NASDAQ:LNSR) at the end of the fourth quarter compared to 5 in the third quarter. In 2024, LENSAR, Inc. (NASDAQ:LNSR) experienced notable revenue growth, with fourth-quarter top-line revenue reaching a record of $16.7 million—marking a 38% increase compared to Q4 2023. While we acknowledge the potential of LENSAR, Inc. (NASDAQ:LNSR) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Associated Press
24-03-2025
- Business
- Associated Press
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders
The Ademi Firm is investigating LENSAR (NASDAQ: LNSR) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon . Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, LENSAR shareholders will receive only $14.00 per share in cash (an aggregate implied value of approximately $356 million*), with an additional non-tradeable contingent value right offering up to $2.75 per share in cash, conditioned on achievement of 614,000 cumulative procedures with LENSAR's products between January 1, 2026, and December 31, 2027. LENSAR insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for LENSAR by imposing a significant penalty if LENSAR accepts a competing bid. We are investigating the conduct of the LENSAR board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Guri Ademi Toll Free: (866) 264-3995 SOURCE: Ademi & Fruchter LLP Copyright Business Wire 2025. PUB: 03/24/2025 09:46 AM/DISC: 03/24/2025 09:47 AM
